About Bio/Pharma Forum on the State of Medicare Reform
CBI’s Bio/Pharma Forum on The State of Medicare Reform is focused on the current healthcare landscape and proposed changes for Medicare.
It is critical that pharmaceutical and biotech manufacturers keep abreast of how the changing healthcare and insurance landscape will impact Medicare strategy.
Attend this elite meeting to stay on the cutting-edge of information related to Medicare Part B and D and gain an early outlook to understand the major impact of the proposed changes.